Gross Margin: 62.25%
Is the gross margin high or low?
The gross margin of 62.25% is in line with its 5-year average of 57.79%, near the high end of its 5-year range (54.44%–62.25%).
As of Friday, June 26, 2026. 1.69% above its 12-month average of 61.21%.
RMD Gross Margin
Reported quarterly gross margin; no daily interpolation.
RMD Average Gross Margin Chart
RMD Current vs Average Gross Margin Chart
RMD Gross Margin Metrics
GROSS MARGIN
62.25%
GROSS MARGIN AVG TTM
61.21%
GROSS MARGIN AVG 3Y
58.47%
GROSS MARGIN AVG 5Y
57.79%
GROSS MARGIN AVG 10Y
57.76%
GROSS MARGIN AVG 15Y
58.88%
GROSS MARGIN AVG 20Y
59.33%
CURRENT VS TTM AVG
+1.69%
CURRENT VS 3Y AVG
+6.46%
CURRENT VS 5Y AVG
+7.71%
CURRENT VS 10Y AVG
+7.77%
CURRENT VS 15Y AVG
+5.71%
CURRENT VS 20Y AVG
+4.92%
RMD Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $28.81B | 62.25% | 61.21% | 58.47% | 57.79% |
| DexCom, Inc. (DXCM)vs › | $26.82B | 61.84% | 60.23% | 62.09% | 63.91% |
| Moderna, Inc. (MRNA)vs › | $26.45B | 55.35% | 54.80% | 53.09% | 65.45% |
| Biogen Inc. (BIIB)vs › | $31.51B | 69.77% | 73.30% | 74.61% | 77.63% |
| IQVIA Holdings Inc. (IQV)vs › | $31.58B | 26.11% | 30.59% | 32.75% | 33.07% |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 74.95% | 75.03% | 73.28% | 73.00% |
| Medline Inc. (MDLN)vs › | $31.94B | 24.04% | 25.55% | 23.71% | 23.71% |
| Zoetis Inc. (ZTS)vs › | $32.06B | 70.75% | 69.79% | 68.91% | 68.46% |
| Centene Corp. (CNC)vs › | $32.31B | 12.24% | 11.28% | 11.33% | 11.71% |
| Mettler-Toledo International Inc. (MTD)vs › | $25.24B | 57.79% | 57.84% | 57.54% | 57.23% |
Gross Margin Analysis
Gross Margin
62.2%
(Revenue - COGS) / Revenue
Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Gross Margin FAQ
- What is the gross margin for ResMed Inc. (RMD)?
- The gross margin for RMD stock is 62.25%.
- Is ResMed Inc.'s gross margin high or low?
- The gross margin of 62.25% is in line with its 5-year average of 57.79%, near the high end of its 5-year range (54.44%–62.25%).
- What is the TTM average gross margin for ResMed Inc. (RMD)?
- The TTM average gross margin for RMD stock is 61.21%.
- What is the 3Y average gross margin for ResMed Inc. (RMD)?
- The 3Y average gross margin for RMD stock is 58.47%.
- What is the 5Y average gross margin for ResMed Inc. (RMD)?
- The 5Y average gross margin for RMD stock is 57.79%.
- What is the 10Y average gross margin for ResMed Inc. (RMD)?
- The 10Y average gross margin for RMD stock is 57.76%.
- What is the 15Y average gross margin for ResMed Inc. (RMD)?
- The 15Y average gross margin for RMD stock is 58.88%.
- What is the 20Y average gross margin for ResMed Inc. (RMD)?
- The 20Y average gross margin for RMD stock is 59.33%.
RMD Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 62.25% |
| 2025-12-31 | 62.18% |
| 2025-09-30 | 61.46% |
| 2025-06-30 | 60.84% |
| 2025-03-31 | 59.33% |
| 2024-12-31 | 58.60% |
| 2024-09-30 | 58.57% |
| 2024-06-30 | 57.58% |
| 2024-03-31 | 56.94% |
| 2023-12-31 | 57.57% |
| 2023-09-30 | 54.44% |
| 2023-06-30 | 55.02% |
| 2023-03-31 | 55.31% |
| 2022-12-31 | 56.08% |
| 2022-09-30 | 56.91% |
| 2022-06-30 | 57.12% |
| 2022-03-31 | 56.82% |
| 2021-12-31 | 56.36% |
| 2021-09-30 | 56.00% |
| 2021-06-30 | 56.01% |
| 2021-03-31 | 58.18% |
| 2020-12-31 | 57.81% |
| 2020-09-30 | 58.34% |
| 2020-06-30 | 58.33% |
| 2020-03-31 | 58.44% |
| 2019-12-31 | 58.02% |
| 2019-09-30 | 59.47% |
| 2019-06-30 | 59.27% |
| 2019-03-31 | 59.18% |
| 2018-12-31 | 58.94% |
| 2018-09-30 | 58.32% |
| 2018-06-30 | 58.12% |
| 2018-03-31 | 58.19% |
| 2017-12-31 | 58.18% |
| 2017-09-30 | 58.36% |
| 2017-06-30 | 58.16% |
| 2017-03-31 | 58.29% |
| 2016-12-31 | 58.27% |
| 2016-09-30 | 57.83% |
| 2016-06-30 | 58.13% |
| 2016-03-31 | 57.26% |
| 2015-12-31 | 58.63% |
| 2015-09-30 | 57.97% |
| 2015-06-30 | 57.26% |
| 2015-03-31 | 59.51% |
| 2014-12-31 | 62.23% |
| 2014-09-30 | 62.39% |
| 2014-06-30 | 62.92% |
| 2014-03-31 | 63.30% |
| 2013-12-31 | 64.72% |
| 2013-09-30 | 63.74% |
| 2013-06-30 | 62.67% |
| 2013-03-31 | 62.42% |
| 2012-12-31 | 61.80% |
| 2012-09-30 | 61.42% |
| 2012-06-30 | 60.89% |
| 2012-03-31 | 60.30% |
| 2011-12-31 | 59.72% |
| 2011-09-30 | 58.79% |
| 2011-06-30 | 58.17% |
| 2011-03-31 | 58.26% |
| 2010-12-31 | 60.79% |
| 2010-09-30 | 61.68% |
| 2010-06-30 | 59.85% |
| 2010-03-31 | 59.78% |
| 2009-12-31 | 59.68% |
| 2009-09-30 | 60.80% |
| 2009-06-30 | 62.20% |
| 2009-03-31 | 60.98% |
| 2008-12-31 | 58.76% |
| 2008-09-30 | 58.33% |
| 2008-06-30 | 57.02% |
| 2008-03-31 | 59.75% |
| 2007-12-31 | 59.86% |
| 2007-09-30 | 60.18% |
| 2007-06-30 | 61.27% |
| 2007-03-31 | 29.64% |
| 2006-12-31 | 62.63% |
| 2006-09-30 | 61.91% |
| 2006-06-30 | 60.87% |
| 2006-03-31 | 62.16% |
| 2005-12-31 | 62.65% |
| 2005-09-30 | 63.02% |
| 2005-06-30 | 63.60% |
| 2005-03-31 | 64.82% |
| 2004-12-31 | 65.82% |
| 2004-09-30 | 64.30% |
| 2004-06-30 | 64.17% |
| 2004-03-31 | 63.05% |
| 2003-12-31 | 63.70% |
| 2003-09-30 | 64.71% |
| 2003-06-30 | 62.41% |
| 2003-03-31 | 62.59% |
| 2002-12-31 | 64.08% |
| 2002-09-30 | 64.34% |
| 2002-06-30 | 65.44% |
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell